Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective
Abstract Background Transfusion-dependent thalassaemia (TDT) is a hereditary blood disorder in which blood transfusion is the Journal mainstay treatment to prolong survival and improve quality of life.Patients with this disease require blood transfusion at more than 100 ml/kg annually and iron-chelating therapy (ICT) to prevent iron overload (IOL)